ArticleFrontiers in pharmacology2022

Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines.

Angela Ragone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.